← Eichor
Study identifier: NCT06647784 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Lateral Positioning and Prone Positioning in ARDS Patients

Condition: ARDS  ·  Sponsor: Centre Hospitalier de Bastia

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Lateral (30°) and alternating positioning (change of side every 30 minutes) carried out on specific beds, could be an alternative or complement to prone positioning (PP) in ARDS patients. The combination of lateralization in prone position has not been studied. The dynamic created by lateralization could allow better overall ventilation during PP, thus making it possible to further improve oxygenation. The main objective of this prospective, bicentric, open, single group study with repeated measures will be to demonstrate that the addition of repeated 30-minute periods of 30° lateralization improves pulmonary aeration in the supine and prone positions in patients with moderate to severe ARDS.

This description comes directly from the study's public registry record.

Talk to the study team

Laurent Papazian, MD,PHD  ·  0495591039  ·  laurent.papazian@ch-bastia.fr

Antoine Faure, PH  ·  0495591111  ·  antoine.faure@ch-bastia.fr

Always discuss trial participation with your own doctor first.

Locations (2)

Bastia General HospitalBastia, France, FranceRecruiting
North Hospital MarseilleMarseille, France, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06647784